Drug
F8IL10
F8IL10 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
3
75%
Ph phase_2
1
25%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Detailed Status
Withdrawn1
Recruiting1
Terminated1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
withdrawn125%
recruiting125%
terminated125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
NCT07245992
withdrawnphase_1
Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment
NCT05622175
terminatedphase_2
A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX
NCT02270632
completedphase_1
Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients
NCT02076659
Clinical Trials (4)
Showing 4 of 4 trials
NCT07245992Phase 1
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
NCT05622175Phase 1
Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment
NCT02270632Phase 2
A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX
NCT02076659Phase 1
Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4